-
公开(公告)号:DE3783988T2
公开(公告)日:1993-08-05
申请号:DE3783988
申请日:1987-08-27
Applicant: TAKEDA CHEMICAL INDUSTRIES LTD
Inventor: TERAO SHINJI , HIRATA MINORU
IPC: A61K31/38 , A61K31/40 , C07C59/64 , C07C59/68 , C07D207/38 , C07D277/06 , C07D333/20 , C07D333/32 , C07D409/06 , C07D487/04 , C07D513/04
-
公开(公告)号:NO172343C
公开(公告)日:1993-07-07
申请号:NO861956
申请日:1986-05-16
Applicant: TAKEDA CHEMICAL INDUSTRIES LTD
Inventor: TERAO SHINJI , HIRATA MINORU
IPC: A61K31/375 , A61K31/40 , A61K31/4025 , A61K31/44 , A61K31/443 , A61K31/535 , A61P1/04 , A61P7/08 , A61P9/00 , A61P9/08 , A61P9/10 , A61P13/02 , A61P15/00 , A61P25/28 , C07D307/62 , C07D405/12 , C07D405/14 , C07D407/04
Abstract: wherein R is organic residue having molecular weight of from 15 to 700, R is hydrogen or hydroxyl, R is hydrogen, acyl, optionally substituted phosphono or sulfo, and R and hydroxyl of R may form acetal residue or ketal residue, and a salt thereof are provided. The compound (I) and salts thereof have excellent prophylactic and improving actions on disorders of circulatory functions, and they are useful as agents of prophylaxis and improvement of circulatory functional disorders.
-
公开(公告)号:DE3783988D1
公开(公告)日:1993-03-18
申请号:DE3783988
申请日:1987-08-27
Applicant: TAKEDA CHEMICAL INDUSTRIES LTD
Inventor: TERAO SHINJI , HIRATA MINORU
IPC: A61K31/38 , A61K31/40 , C07C59/64 , C07C59/68 , C07D207/38 , C07D277/06 , C07D333/20 , C07D333/32 , C07D409/06 , C07D487/04 , C07D513/04
-
公开(公告)号:CA1300143C
公开(公告)日:1992-05-05
申请号:CA510045
申请日:1986-05-27
Applicant: TAKEDA CHEMICAL INDUSTRIES LTD
Inventor: SUGIHARA HIROSADA , HIRATA MINORU
IPC: A61K31/38 , C07D313/08 , C07D321/10 , C07D337/08 , C07D405/06 , C07D405/12 , C07D407/12 , C07D409/06 , C07D409/12
Abstract: Novel condensed seven-membered heterocyclic compounds of the formula: wherein R1 and R2 are independently hydrogen, halogen, hydroxy, lower alkyl or lower alkoxy, R3 and R4 are independently hydrogen, optionally substituted lower alkyl, optionally substituted cycloalkyl or optionally substituted aralkyl, or both jointly form an optionally substituted ring together with the adjacent nitrogen atom, X is hydrogen, optionally substituted lower alkyl, optionally substituted aryl or a carboxyl group which may be esterified or amidated, Y is or in which R5 is hydrogen, acyl or optioinally substituted carbamoyl, A is oxygen atom or sulfur atom, E is oxygen atom or methylene, and G is lower alkylene, provided that when A is sulfur atom, E is methylene, and salts thereof exhibit serotonin S2 receptor blocking activity, actions to relieve cerebral vasospasm and antithrombotic activity, and are of value as a prophylactic and therapeutic agent for ischemic cardiopathies, thrombosis, hypertension and cerebral circulatory disorders.
-
公开(公告)号:FI86180B
公开(公告)日:1992-04-15
申请号:FI851286
申请日:1985-03-29
Applicant: TAKEDA CHEMICAL INDUSTRIES LTD
Inventor: TERAO SHINJI , HIRATA MINORU
IPC: C07D20060101 , C07D307/62
-
公开(公告)号:NO167734C
公开(公告)日:1991-12-04
申请号:NO880511
申请日:1988-02-05
Applicant: TAKEDA CHEMICAL INDUSTRIES LTD
Inventor: TSUSHIMA SUSUMU , TAKATANI MUNEO , HIRATA MINORU
IPC: C07C271/10 , A61K20060101 , A61K31/27 , A61K31/325 , A61K31/335 , A61K31/395 , A61K31/44 , A61K31/4402 , A61K31/4406 , A61K31/4409 , A61K31/4418 , A61K31/445 , A61K31/4465 , A61K31/4468 , A61P9/06 , C07C20060101 , C07C269/02 , C07C271/06 , C07C271/12 , C07C271/24 , C07C271/28 , C07C275/00 , C07C275/14 , C07C275/28 , C07C323/25 , C07C333/04 , C07C333/06 , C07C333/10 , C07D209/48 , C07D211/04 , C07D211/34 , C07D211/58 , C07D213/24 , C07D213/36 , C07D213/38 , C07D213/53 , C07D295/10 , C07D295/12 , C07D295/125 , C07D295/13 , C07D521/00
-
公开(公告)号:AU607180B2
公开(公告)日:1991-02-28
申请号:AU1136088
申请日:1988-02-05
Applicant: TAKEDA CHEMICAL INDUSTRIES LTD
Inventor: TSUSHIMA SUSUMU , TAKATANI MUNEO , HIRATA MINORU
IPC: C07C271/10 , A61K20060101 , A61K31/27 , A61K31/325 , A61K31/335 , A61K31/395 , A61K31/44 , A61K31/4402 , A61K31/4406 , A61K31/4409 , A61K31/4418 , A61K31/445 , A61K31/4465 , A61K31/4468 , A61P9/06 , C07C20060101 , C07C269/02 , C07C271/06 , C07C271/12 , C07C271/24 , C07C271/28 , C07C275/00 , C07C275/14 , C07C275/28 , C07C323/25 , C07C333/04 , C07C333/06 , C07C333/10 , C07D209/48 , C07D211/04 , C07D211/34 , C07D211/58 , C07D213/24 , C07D213/36 , C07D213/38 , C07D213/53 , C07D295/10 , C07D295/12 , C07D295/125 , C07D295/13 , C07D521/00 , A61K31/535 , C07C269/04 , C07C269/06 , C07C271/20 , C07C333/20 , C07D211/26
-
8.
公开(公告)号:HU201922B
公开(公告)日:1991-01-28
申请号:HU465784
申请日:1984-12-13
Applicant: TAKEDA CHEMICAL INDUSTRIES LTD
Inventor: HIRATA MINORU , SUGIHARA HIROSADA
IPC: A61K31/385 , A61K31/39 , A61K31/495 , A61P11/00 , C07D327/02 , C07D411/06 , C07D411/12 , C07D413/06
Abstract: Novel 1,5-benzoxathiepin derivatives of the formula: [wherein R1 and R2 are independently hydrogen, halogen, hydroxy, lower alkyl or lower alkoxy; R3 and R4 are independently hydrogen, optionally substituted lower alkyl or optionally substituted cycloalkyl or optionally substituted aralkyl, or both jointly form an optionally substituted ring together with the adjacent nitrogen atom; X is hydrogen, optionally substituted lower alkyl, optionally substituted aryl or a carboxyl group which may be esterified or amidated; Y is &rdurule& C=O or &rdurule& CH-OR5 (wherein R5 is hydrogen, acyl or optionally substituted carbamoyl); m is an integer of 0 to 2; n is an integer of 1 to 6] and salts thereof exhibit serotonin S2 receptor blocking activity, calcium antagonism, actions to relieve cerebral vasospasm and to improve renal circulation and diuretic and antithrombotic activities, and are of value as a prophylactic and therapeutic agent for ischemic cardiopathies, thrombosis, hypertension and cerebral circulatory disorders.
-
公开(公告)号:CA1271754A
公开(公告)日:1990-07-17
申请号:CA524173
申请日:1986-12-01
Applicant: TAKEDA CHEMICAL INDUSTRIES LTD
Inventor: SUGIHARA HIROSADA , HIRATA MINORU
IPC: A61K31/39 , A61P43/00 , C07D327/02 , C07D411/06 , A61K31/495
Abstract: 24205-694 Compounds of the formula: wherein R is hydroxy or lower alkoxy and X is lower alkoxycarbonyl, and their salts possess serotonin S2 receptor blocking activity, calcium antagonism, actions to relieve cerebral vasospasm and to improve renal circulation, and diuretic and antithrombotic activities, and are useful as prophylactic and therapeutic agents for ischemic cardiopathies, thrombosis, hypertension and cerebral circulatory disorders.
-
公开(公告)号:AT50494T
公开(公告)日:1990-03-15
申请号:AT86106521
申请日:1986-05-14
Applicant: TAKEDA CHEMICAL INDUSTRIES LTD
Inventor: TERAO SHINJI , HIRATA MINORU
IPC: A61K31/375 , C07D307/62
-
-
-
-
-
-
-
-
-